Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia

Kengo Oishi, Nobuhisa Kanahara, Masayuki Takase, Yasunori Oda, Yusuke Nakata, Tomihisa Niitsu, Masatomo Ishikawa, Yasunori Sato, Masaomi Iyo

Research output: Contribution to journalArticle

Abstract

Background A significant portion of patients with schizophrenia who respond to initial antipsychotic treatment acquire treatment resistance. One of the possible pathogeneses of treatment-resistant schizophrenia (TRS) is antipsychotic-induced dopamine supersensitivity psychosis (Ai-DSP). Patients with this disease progression might share some genetic vulnerabilities, and thus determining individuals with higher risks of developing Ai-DSP could contribute to preventing iatrogenic development of TRS. Therefore, we decided to examine whether combinations of functional single nucleotide polymorphisms (SNPs) known to affect dopaminergic functions are related to Ai-DSP development. Methods In this case-control study, 357 Japanese participants diagnosed with schizophrenia or schizoaffective disorder were recruited and divided into two groups, those with and without Ai-DSP. As functional SNPs, we examined rs10770141 of the tyrosine hydroxylase gene, rs4680 of the catechol-O-methyltransferase gene, and rs1799732 and rs1800497 of the DRD2 genes, which are known to possess strong directional ties to dopamine synthesis, dopamine degradation and post-synaptic DRD2 prevalence, respectively. Results Among the 357 Japanese patients with schizophrenia or schizoaffective disorder, 130 were classified as Ai-DSP(+) and the other 227 as Ai-DSP(-). Significantly higher proportions of Ai-DSP(+) patients were found to have the SNP combinations of rs10770141/rs4680 (57.9%, OR2.654, 95%CI1.036–6.787, P = 0.048) and rs10770141/rs4680/rs1800497 (64.3%, OR4.230, 95%CI1.306–13.619, P = 0.029). However, no single SNP was associated with Ai-DSP. Conclusions We preliminarily found that carrying particular combinations of functional SNPs, which are related to relatively higher dopamine synthesis and dopamine degradation and lower naïve DRD2, might indicate vulnerability to development of Ai-DSP. However, further studies are needed to validate the present results.

Original languageEnglish
Article numbere0207133
JournalPloS one
Volume13
Issue number11
DOIs
Publication statusPublished - 2018 Nov 1
Externally publishedYes

Fingerprint

dopamine
Polymorphism
Dopamine
Schizophrenia
Psychotic Disorders
genetic polymorphism
Antipsychotic Agents
single nucleotide polymorphism
Single Nucleotide Polymorphism
Nucleotides
Therapeutics
Genes
schizophrenia
tyrosine 3-monooxygenase
catechol O-methyltransferase
antipsychotics
Catechol O-Methyltransferase
Degradation
synthesis
degradation

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Oishi, K., Kanahara, N., Takase, M., Oda, Y., Nakata, Y., Niitsu, T., ... Iyo, M. (2018). Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia. PloS one, 13(11), [e0207133]. https://doi.org/10.1371/journal.pone.0207133

Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia. / Oishi, Kengo; Kanahara, Nobuhisa; Takase, Masayuki; Oda, Yasunori; Nakata, Yusuke; Niitsu, Tomihisa; Ishikawa, Masatomo; Sato, Yasunori; Iyo, Masaomi.

In: PloS one, Vol. 13, No. 11, e0207133, 01.11.2018.

Research output: Contribution to journalArticle

Oishi, K, Kanahara, N, Takase, M, Oda, Y, Nakata, Y, Niitsu, T, Ishikawa, M, Sato, Y & Iyo, M 2018, 'Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia', PloS one, vol. 13, no. 11, e0207133. https://doi.org/10.1371/journal.pone.0207133
Oishi, Kengo ; Kanahara, Nobuhisa ; Takase, Masayuki ; Oda, Yasunori ; Nakata, Yusuke ; Niitsu, Tomihisa ; Ishikawa, Masatomo ; Sato, Yasunori ; Iyo, Masaomi. / Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia. In: PloS one. 2018 ; Vol. 13, No. 11.
@article{467ac294f5734a078d9d3aa51a5fe72f,
title = "Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia",
abstract = "Background A significant portion of patients with schizophrenia who respond to initial antipsychotic treatment acquire treatment resistance. One of the possible pathogeneses of treatment-resistant schizophrenia (TRS) is antipsychotic-induced dopamine supersensitivity psychosis (Ai-DSP). Patients with this disease progression might share some genetic vulnerabilities, and thus determining individuals with higher risks of developing Ai-DSP could contribute to preventing iatrogenic development of TRS. Therefore, we decided to examine whether combinations of functional single nucleotide polymorphisms (SNPs) known to affect dopaminergic functions are related to Ai-DSP development. Methods In this case-control study, 357 Japanese participants diagnosed with schizophrenia or schizoaffective disorder were recruited and divided into two groups, those with and without Ai-DSP. As functional SNPs, we examined rs10770141 of the tyrosine hydroxylase gene, rs4680 of the catechol-O-methyltransferase gene, and rs1799732 and rs1800497 of the DRD2 genes, which are known to possess strong directional ties to dopamine synthesis, dopamine degradation and post-synaptic DRD2 prevalence, respectively. Results Among the 357 Japanese patients with schizophrenia or schizoaffective disorder, 130 were classified as Ai-DSP(+) and the other 227 as Ai-DSP(-). Significantly higher proportions of Ai-DSP(+) patients were found to have the SNP combinations of rs10770141/rs4680 (57.9{\%}, OR2.654, 95{\%}CI1.036–6.787, P = 0.048) and rs10770141/rs4680/rs1800497 (64.3{\%}, OR4.230, 95{\%}CI1.306–13.619, P = 0.029). However, no single SNP was associated with Ai-DSP. Conclusions We preliminarily found that carrying particular combinations of functional SNPs, which are related to relatively higher dopamine synthesis and dopamine degradation and lower na{\"i}ve DRD2, might indicate vulnerability to development of Ai-DSP. However, further studies are needed to validate the present results.",
author = "Kengo Oishi and Nobuhisa Kanahara and Masayuki Takase and Yasunori Oda and Yusuke Nakata and Tomihisa Niitsu and Masatomo Ishikawa and Yasunori Sato and Masaomi Iyo",
year = "2018",
month = "11",
day = "1",
doi = "10.1371/journal.pone.0207133",
language = "English",
volume = "13",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "11",

}

TY - JOUR

T1 - Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia

AU - Oishi, Kengo

AU - Kanahara, Nobuhisa

AU - Takase, Masayuki

AU - Oda, Yasunori

AU - Nakata, Yusuke

AU - Niitsu, Tomihisa

AU - Ishikawa, Masatomo

AU - Sato, Yasunori

AU - Iyo, Masaomi

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Background A significant portion of patients with schizophrenia who respond to initial antipsychotic treatment acquire treatment resistance. One of the possible pathogeneses of treatment-resistant schizophrenia (TRS) is antipsychotic-induced dopamine supersensitivity psychosis (Ai-DSP). Patients with this disease progression might share some genetic vulnerabilities, and thus determining individuals with higher risks of developing Ai-DSP could contribute to preventing iatrogenic development of TRS. Therefore, we decided to examine whether combinations of functional single nucleotide polymorphisms (SNPs) known to affect dopaminergic functions are related to Ai-DSP development. Methods In this case-control study, 357 Japanese participants diagnosed with schizophrenia or schizoaffective disorder were recruited and divided into two groups, those with and without Ai-DSP. As functional SNPs, we examined rs10770141 of the tyrosine hydroxylase gene, rs4680 of the catechol-O-methyltransferase gene, and rs1799732 and rs1800497 of the DRD2 genes, which are known to possess strong directional ties to dopamine synthesis, dopamine degradation and post-synaptic DRD2 prevalence, respectively. Results Among the 357 Japanese patients with schizophrenia or schizoaffective disorder, 130 were classified as Ai-DSP(+) and the other 227 as Ai-DSP(-). Significantly higher proportions of Ai-DSP(+) patients were found to have the SNP combinations of rs10770141/rs4680 (57.9%, OR2.654, 95%CI1.036–6.787, P = 0.048) and rs10770141/rs4680/rs1800497 (64.3%, OR4.230, 95%CI1.306–13.619, P = 0.029). However, no single SNP was associated with Ai-DSP. Conclusions We preliminarily found that carrying particular combinations of functional SNPs, which are related to relatively higher dopamine synthesis and dopamine degradation and lower naïve DRD2, might indicate vulnerability to development of Ai-DSP. However, further studies are needed to validate the present results.

AB - Background A significant portion of patients with schizophrenia who respond to initial antipsychotic treatment acquire treatment resistance. One of the possible pathogeneses of treatment-resistant schizophrenia (TRS) is antipsychotic-induced dopamine supersensitivity psychosis (Ai-DSP). Patients with this disease progression might share some genetic vulnerabilities, and thus determining individuals with higher risks of developing Ai-DSP could contribute to preventing iatrogenic development of TRS. Therefore, we decided to examine whether combinations of functional single nucleotide polymorphisms (SNPs) known to affect dopaminergic functions are related to Ai-DSP development. Methods In this case-control study, 357 Japanese participants diagnosed with schizophrenia or schizoaffective disorder were recruited and divided into two groups, those with and without Ai-DSP. As functional SNPs, we examined rs10770141 of the tyrosine hydroxylase gene, rs4680 of the catechol-O-methyltransferase gene, and rs1799732 and rs1800497 of the DRD2 genes, which are known to possess strong directional ties to dopamine synthesis, dopamine degradation and post-synaptic DRD2 prevalence, respectively. Results Among the 357 Japanese patients with schizophrenia or schizoaffective disorder, 130 were classified as Ai-DSP(+) and the other 227 as Ai-DSP(-). Significantly higher proportions of Ai-DSP(+) patients were found to have the SNP combinations of rs10770141/rs4680 (57.9%, OR2.654, 95%CI1.036–6.787, P = 0.048) and rs10770141/rs4680/rs1800497 (64.3%, OR4.230, 95%CI1.306–13.619, P = 0.029). However, no single SNP was associated with Ai-DSP. Conclusions We preliminarily found that carrying particular combinations of functional SNPs, which are related to relatively higher dopamine synthesis and dopamine degradation and lower naïve DRD2, might indicate vulnerability to development of Ai-DSP. However, further studies are needed to validate the present results.

UR - http://www.scopus.com/inward/record.url?scp=85056394696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056394696&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0207133

DO - 10.1371/journal.pone.0207133

M3 - Article

C2 - 30408108

AN - SCOPUS:85056394696

VL - 13

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 11

M1 - e0207133

ER -